Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Didn't your parents ever tell you not to take drugs?? You should have listened.
Isn't the 500k purchase order with Potencia considered revenue? Plus if they were a scam working out of a cubicle with 6 other companies, Potencia and Motorino wouldn't be even looking their way. Mark Godsy has put over 150k of his own money into this company. That's a lot of confidence. Plus Sue Ozdemir left a giant multi billion dollar company Wolong to join Exro. Even though we haven't heard from her yet! Lol.
From Max Jacob's yesterday, a mistake on the USPTO website. Being fixed. If there was an issue with the EB patent? They would delay Clinical trials, they're not. A. Mancini wouldn't have bought 160k+ shares over the last two weeks. Not worried.
Well. Private placement or not. Mark Godsy buying 10k+ shares every day for the last two weeks is giving me confidence. That's not Including the 100k he contributed to the PP. Every company needs money to operate, especially startups! Like Nebula said, I feel good about this one!
Mark Godsy continues to buy!!
https://ceo.ca/xro
What is the major difference Mark Godsy buying 370k shares as a part of the PP compared to buying 370k shares on the open market? He's still risking 100k with Exro!
I could be wrong!
Mark's purchase says investments and indirect ownership.
No it wasn't. Look under her purchase. It says direct ownership.
Yes, I looked at it again. Mark Godsy's big purchase of 370k shares was part of the PP! All the other purchases today were direct ownership.
I think because this wasn't open market purchases! I believe these purchases were part of the private placement.
That's awesome!! I just noticed that Mark bought an additional 30k shares today on top of the 370k! I'm getting pretty excited right now! Lol.
Did you notice Sue bought 37k at $9'999.00 and Mark bought 370k at 99,999.00! I wonder what the meaning of that is??
I wonder if that's part of the private placement?
Sue bought 37k shares today!
https://ceo.ca/xro
From reading this article, I believe our SP will take a small hit short term. I also believe the financing will be put to good use and it will pay off for us hopefully sooner rather than later!
https://www.investopedia.com/ask/answers/052815/how-does-private-placement-affect-share-price.asp
A. Mancini spent some more lunch money today.
https://ceo.ca/in
Insider buying?
You must buy some expensive lunches! A. Mancini over the last week and a half purchased 120k shares! Roughly 31k That's a little more than lunch money!
From Tim. What he says makes 100% complete sense!
Perhaps it's a bit early for a minor cannabinoid market?
I don't want to raise any unnecessary concerns but it's worth having a little reality check. Regardless of what the "competitors" are doing in biosynthesis, I think InMed will likely be first to market with a minor cannabinoid because they will have the toxicology and safety studies completed to go along with any minor cannabinoid they intend to produce.
The important thing for us to understand is that there are important steps before anyone can use products with minor cannabinoids. They must be tested. I don't pretend to know the FDA process for approval of cannabinoids but one thing is clear, InMed had to conduct toxicology studies on their undisclosed cannabinoid and have an application for phase 1 trials in humans.
As a result, I am assuming that the use of any of the minor cannabinoids in anything more than the trace amounts found in the natural plant extract will likely have to go through toxicology and phase 1 safety trials.
Eric Adams stated that "When the time is right" they would announce a plan for commercialization. I think it is safe to assume that the time will be right when the cost of production is less than the extraction cost and there is a viable market for new cannabinoids.
There is a cost to do toxicology and safety studies so there is definitely a chicken and egg problem. One company is going to have to have an economic model for creating a market before the products are launched. Apple was a big and profitable company when they release the iPad and iphone. That was a huge investment for a market that didn't exist.
So which competitors are going to have the wherewithal to self-fund a Research Use Only product ahead of regulatory approval? The short answer is the companies doing active research in the application of minor cannabinoids. That, I believe, is only GW and InMed at the moment.
So in InMed's case, I am guessing the time will be right when they announce the results of their phase 1 and they can package their unique, minor cannabinoid with a safety certification for cosmetics or pharmaceutical companies to test out.
For a pure-play manufacturing company, they only short-term or midterm revenue stream would be for CBD or THC. I may be wrong but I believe these cannabinoids are going down to commodity pricing levels.
Just a few thoughts with no particular conclusion. I still have clinical trials and pharmaceutical applications as my value driver in my investment thesis.
Once we see purchase orders? I'll believe Teewinot can do what they claim!
Actually she has 120k now! She bought another 10k today.
"Ground Control to Major Tom"
How do you go from Bowing and Tesla rumors to being concerned about cash burn rate? BTW, question. I dig every single thing I can on this company and never ever see anything about the rumors you speak of? What is your source of these rumors?
Mark Godsy grabbed another 20k shares today!
He/She can only sell for so long and we will keep gobbling up those shares! Only a matter of time! That person will regret selling all those shares at some point.
I actually just got you're message. Thank you.
This should put an end to the rumors of Alexandra Mancini leaving the company!
https://m.canadianinsider.com/node/7?menu_tickersearch=IN+%7C+InMed+Pharmaceuticals
Mark Godsy has purchased 80k shares over the last 2 days! That's a nice vote of confidence!
Hopefully some news coming soon. She's hanging tough in the meantime!
HB, when you get a chance can I please get the name and number to the NRC person you spoke with. Thanks.
He is a share holder. If he's involved with Inmed? That I don't know!
Total outsider? Nope. The guy has forgotten more than we all will ever know about Biotech!
Tim works in Vancouver, over 30 years experience in the Biotech sector and industry. He knows all the ins and outs.
HB, I would like the name and number to the NRC guy you spoke with.
We will see who was right next year and 2021 when Inmed takes off!
Les, you are 100% right! Management has done nothing wrong. Also they speak of people jumping ship, false!! Ado Mohammed is still a consultant. Dr Sazzad Hossain is battling illness and is working on some other big things. Parts has to do with fighting his illness. Jeff Charpentier is still with Inmed as Vice president of finance. BTW, Martin Bott was forced to step off the BOD because Catherine Sazdanoff is a monster and there was not enough room for both. If people really pay attention to the updates, you see things are progressing and moving forward. Sorry that this science isn't making everyone here rich in a timely fashion. People need to know Inmed is trying to become a pharmaceutical company. Biosynthesis will be icing on the cake. Takes time.
If you hear anything, please share. In the future, I can totally see it.
Did you read that somewhere?